Mkt Cap$2.34T-0.50%
24h Vol$79.50B
BTC Dom56.3%
ETH Dom9.2%
F&G23Extreme Fear
BTC$65,637.00-0.89% ETH$1,790.31+0.01% USDT$0.9991-0.04% BNB$605.24-1.89% XRP$1.22-1.90% USDC$0.99980.00% SOL$73.62-0.36% TRX$0.3165-0.75% FIGR_HELOC$1.04+0.75% HYPE$72.98+9.26% DOGE$0.0872-0.91% USDS$0.9997-0.01% LEO$9.74+0.01% RAIN$0.0142+2.95% ZEC$506.97-1.92% XLM$0.2186+1.74% BTC$65,637.00-0.89% ETH$1,790.31+0.01% USDT$0.9991-0.04% BNB$605.24-1.89% XRP$1.22-1.90% USDC$0.99980.00% SOL$73.62-0.36% TRX$0.3165-0.75% FIGR_HELOC$1.04+0.75% HYPE$72.98+9.26% DOGE$0.0872-0.91% USDS$0.9997-0.01% LEO$9.74+0.01% RAIN$0.0142+2.95% ZEC$506.97-1.92% XLM$0.2186+1.74%
News

Market Analysis

Total Stories
2,790
Section
Market Analysis
Why Is VNDA Stock Surging Premarket? FDA Approves Motion Sickness Drug
Market Analysis

Why Is VNDA Stock Surging Premarket? FDA Approves Motion Sickness Drug

Vanda Pharmaceuticals stock surged nearly 19% in premarket trading after receiving FDA approval for NEREUS, the first new motion sickness treatment in over 40 years, with the company expecting to…

Tim FriesDec 31, 20253 min read